These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7074569)

  • 1. So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases.
    Holland R; Mravunac M; Hendriks JH; Bekker BV
    Cancer; 1982 Jun; 49(12):2527-33. PubMed ID: 7074569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
    van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
    J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups.
    Brekelmans CT; van Gorp JM; Peeters PH; Collette HJ
    Cancer; 1996 Sep; 78(6):1220-8. PubMed ID: 8826943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Cancer; 1993 Sep; 72(6):1933-8. PubMed ID: 8364871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence of interval cancers in the Nijmegen screening programme.
    Peeters PH; Verbeek AL; Hendriks JH; Holland R; Mravunac M; Vooijs GP
    Br J Cancer; 1989 Jun; 59(6):929-32. PubMed ID: 2736229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.
    Emaus MJ; Bakker MF; Peeters PH; Loo CE; Mann RM; de Jong MD; Bisschops RH; Veltman J; Duvivier KM; Lobbes MB; Pijnappel RM; Karssemeijer N; de Koning HJ; van den Bosch MA; Monninkhof EM; Mali WP; Veldhuis WB; van Gils CH
    Radiology; 2015 Nov; 277(2):527-37. PubMed ID: 26110667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.
    Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F
    AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
    van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of full field digital mammography on the classification and mammographic characteristics of interval breast cancers.
    Knox M; O'Brien A; Szabó E; Smith CS; Fenlon HM; McNicholas MM; Flanagan FL
    Eur J Radiol; 2015 Jun; 84(6):1056-61. PubMed ID: 25816990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
    Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.